The drug’s global sales were estimated to be about $28 billion last year, according to FactSet. Novo Nordisk said Friday it ...

citing reductions in government funding of Medicare. That was above the FactSet consensus of 85.1%. Mizuho analyst Ann Hynes said she believes the higher-than-expected cost trend, coming with ...

UnitedHealth posted a better-than-expected profit in the final quarter of 2024, but revenue fell short as challenges like Medicare funding cuts and a Medicaid enrollment drop hurt ...

The top line of UnitedHealthcare, the company's insurance and managed care business, rose 6.1% to $74.1 billion. Analysts had been looking for $75.22 billion. Revenue from Optum, its ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

Adjusted per-share earnings in the fourth quarter for UnitedHealth top analysts’ estimates but revenue comes up short.

UnitedHealth posted a better-than-expected profit in the final quarter of 2024, but revenue fell short as challenges like ...

UnitedHealth said it was still dealing with an increase in prescriptions for expensive specialty drugs, rate cuts to its federally funded Medicare ... to the data firm FactSet.

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

Witty also cited several challenges in 2024, including the Biden administration’s Medicare rate cuts ... according to FactSet. The company affirmed its 2025 outlook. Though the flurry of ...

Walgreens booked a better-than-expected fiscal first quarter, but the drugstore chain lost $265 million as it closed U.S. stores and continued work to revive its business. The company, beset by ...